Upregulation of heme oxygenase-1 with hemin prevents D-galactosamine and lipopolysaccharide-induced acute hepatic injury in rats

被引:70
作者
Wen, Tao [1 ]
Wu, Zhi-Ming
Liu, Yan
Tan, Yu-Fen
Rena, Feng
Wu, Hao
机构
[1] Capital Univ Med Sci, Beijing You An Hosp, Inst Liver Dis, Beijing 100069, Peoples R China
[2] Capital Univ Med Sci, Beijing You An Hosp, Dept Infect Dis, Beijing 100069, Peoples R China
关键词
heme oxygenase-1 (HO-1); liver injury; D-galactosamine (GalN); hemin; tumor necrosis factor-alpha (TNF-alpha); caspase-3;
D O I
10.1016/j.tox.2007.05.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Heme oxygenase-1 (HO-1), the rate-limiting enzyme in heme catabolism, has been shown to be induced during oxidative injury, and its induction acts as an important cellular defense mechanism against such injuries. In this study, we examined the functional roles of HO-1 induction in a rat model of D-galactosamine (GalN) and lipopolysaccharide (LPS)-induced liver injury. We found that GalN/LPS treatment of rats produced severe hepatic injury, whereas upregulation of HO-1 by hemin pretreatment prevented rats from liver damage, as evidenced by decreased serum ALT, AST levels and ameliorated histological signs in the liver. Induction of HO-1 resulted in a significant decrease in hepatic malondialdehyde (MDA) contents, tumor necrosis factor-alpha. (TNF-alpha) levels, iNOS/NO production, as well as the levels of caspase-3. In contrast, inhibition of HO activity by zinc protoporphyrin-9 (ZnPP, a specific inhibitor of HO) completely reversed HO-1-induced hepatoprotective effect. These data therefore suggested that HO-1 induction provided critical protection against GalN/LPS-induced liver injury, and the protection seemed to be mediated through the anti-oxidant, anti-inflammatory and anti-apoptotic functions. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:184 / 193
页数:10
相关论文
共 42 条
[1]   Anti-inflammatory actions of the heme oxygenase-1 pathway [J].
Alcaraz, MJ ;
Fernandez, P ;
Guillén, MI .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (30) :2541-2551
[2]   Differential expression of mouse hepatic transporter genes in response to acetaminophen and carbon tetrachloride [J].
Aleksunes, LM ;
Slitt, AM ;
Cherrington, NJ ;
Thibodeau, MS ;
Klaassen, CD ;
Manautou, JE .
TOXICOLOGICAL SCIENCES, 2005, 83 (01) :44-52
[3]   Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury [J].
Amersi, F ;
Buelow, R ;
Kato, H ;
Ke, BB ;
Coito, AJ ;
Shen, XD ;
Zhao, DL ;
Zaky, J ;
Melinek, J ;
Lassman, CR ;
Kolls, JK ;
Alam, J ;
Ritter, T ;
Volk, HD ;
Farmer, DG ;
Ghobrial, RM ;
Busuttil, RW ;
Kupiec-Weglinski, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (11) :1631-1639
[4]   Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway [J].
Amersi, F ;
Shen, XD ;
Anselmo, D ;
Melinek, J ;
Iyer, S ;
Southard, DJ ;
Katori, M ;
Volk, HD ;
Busuttil, RW ;
Buelow, R ;
Kupiec-Weglinski, JW .
HEPATOLOGY, 2002, 35 (04) :815-823
[5]   Expression pattern of heme oxygenase isoenzymes 1 and 2 in normal and stress-exposed rat liver [J].
Bauer, I ;
Wanner, GA ;
Rensing, H ;
Alte, G ;
Miescher, EA ;
Wolf, B ;
Pannen, BHJ ;
Clemens, MG ;
Bauer, M .
HEPATOLOGY, 1998, 27 (03) :829-838
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-κB to protect endothelial cells from tumor necrosis factor-α-mediated apoptosis [J].
Brouard, S ;
Berberat, PO ;
Tobiasch, E ;
Seldon, MP ;
Bach, FH ;
Soares, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (20) :17950-17961
[8]   Increased vascular heme oxygenase-1 expression contributes to arterial vasodilation in experimental cirrhosis in rats [J].
Chen, YC ;
Ginès, P ;
Yang, JH ;
Summer, SN ;
Falk, S ;
Russell, NS ;
Schrier, RW .
HEPATOLOGY, 2004, 39 (04) :1075-1087
[9]   Differential induction of heme oxygenase-1 in macrophages and hepatocytes during acetaminophen-induced hepatotoxicity in the rat: Effects of hemin and biliverdin [J].
Chiu, H ;
Brittingham, JA ;
Laskin, DL .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2002, 181 (02) :106-115
[10]  
DRAPER HH, 1990, METHOD ENZYMOL, V186, P421